Simply Cells was founded by Dr Erik Miljan to address the interface between technology and commercialisation.
Dr Miljan holds a Phd in Biochemistry and has over 10 years’ experience in the Stem Cell Biotech sector, from intellectual property (IP) portfolio management through product development to regulatory approval.
Initiated, implemented and delivered the operational and management strategy leading to the first ever stem cell based product approved for clinical trial in the United Kingdom in addition to delivering non-therapeutic stem cell products to market.
“We used Simplycells to project manage the implementation of our new DataRoom. They provided first class, practical advice and a value for money solution in getting the DataRoom fully operational, on time and on budget” Pat Huggins, ReNeuron Ltd